These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 10571777)

  • 41. Growth factor ultrafiltration in experimental diabetic nephropathy contributes to interstitial fibrosis.
    Wang SN; Hirschberg R
    Am J Physiol Renal Physiol; 2000 Apr; 278(4):F554-60. PubMed ID: 10751215
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The renal expression of transforming growth factor-beta isoforms and their receptors in acute and chronic experimental diabetes in rats.
    Hill C; Flyvbjerg A; Grønbaek H; Petrik J; Hill DJ; Thomas CR; Sheppard MC; Logan A
    Endocrinology; 2000 Mar; 141(3):1196-208. PubMed ID: 10698197
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cyclin kinase inhibitor p21CIP1/WAF1 limits interstitial cell proliferation following ureteric obstruction.
    Hughes J; Brown P; Shankland SJ
    Am J Physiol; 1999 Dec; 277(6):F948-56. PubMed ID: 10600942
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Parathyroid hormone-related protein is a hypertrophy factor for human mesangial cells: Implications for diabetic nephropathy.
    Ortega A; Romero M; Izquierdo A; Troyano N; Arce Y; Ardura JA; Arenas MI; Bover J; Esbrit P; Bosch RJ
    J Cell Physiol; 2012 May; 227(5):1980-7. PubMed ID: 21732369
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heterozygous mice for TGF-betaIIR gene are resistant to the progression of streptozotocin-induced diabetic nephropathy.
    Kim HW; Kim BC; Song CY; Kim JH; Hong HK; Lee HS
    Kidney Int; 2004 Nov; 66(5):1859-65. PubMed ID: 15496156
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of mTOR signaling with rapamycin attenuates renal hypertrophy in the early diabetic mice.
    Sakaguchi M; Isono M; Isshiki K; Sugimoto T; Koya D; Kashiwagi A
    Biochem Biophys Res Commun; 2006 Feb; 340(1):296-301. PubMed ID: 16364254
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Calcineurin is activated in diabetes and is required for glomerular hypertrophy and ECM accumulation.
    Gooch JL; Barnes JL; Garcia S; Abboud HE
    Am J Physiol Renal Physiol; 2003 Jan; 284(1):F144-54. PubMed ID: 12388427
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The genetics of hypertension modifies the renal cell replication response induced by experimental diabetes.
    Silveira LA; Bacchi CE; Pinto GA; De Faria JB
    Diabetes; 2002 May; 51(5):1529-34. PubMed ID: 11978652
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli.
    Xu ZG; Yoo TH; Ryu DR; Cheon Park H; Ha SK; Han DS; Adler SG; Natarajan R; Kang SW
    Kidney Int; 2005 Mar; 67(3):944-52. PubMed ID: 15698433
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hyperglycemia and hyperlipidemia act synergistically to induce renal disease in LDL receptor-deficient BALB mice.
    Spencer MW; Mühlfeld AS; Segerer S; Hudkins KL; Kirk E; LeBoeuf RC; Alpers CE
    Am J Nephrol; 2004; 24(1):20-31. PubMed ID: 14671436
    [TBL] [Abstract][Full Text] [Related]  

  • 51. F(2)-isoprostanes mediate high glucose-induced TGF-beta synthesis and glomerular proteinuria in experimental type I diabetes.
    Montero A; Munger KA; Khan RZ; Valdivielso JM; Morrow JD; Guasch A; Ziyadeh FN; Badr KF
    Kidney Int; 2000 Nov; 58(5):1963-72. PubMed ID: 11044216
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decorin deficiency enhances progressive nephropathy in diabetic mice.
    Williams KJ; Qiu G; Usui HK; Dunn SR; McCue P; Bottinger E; Iozzo RV; Sharma K
    Am J Pathol; 2007 Nov; 171(5):1441-50. PubMed ID: 17884968
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thrombospondin-1 is an endogenous activator of TGF-beta in experimental diabetic nephropathy in vivo.
    Daniel C; Schaub K; Amann K; Lawler J; Hugo C
    Diabetes; 2007 Dec; 56(12):2982-9. PubMed ID: 17878288
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Beta-hydroxybutyrate-induced growth inhibition and collagen production in HK-2 cells are dependent on TGF-beta and Smad3.
    Guh JY; Chuang TD; Chen HC; Hung WC; Lai YH; Shin SJ; Chuang LY
    Kidney Int; 2003 Dec; 64(6):2041-51. PubMed ID: 14633126
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Beneficial effects of spironolactone on glomerular injury in streptozotocin-induced diabetic rats.
    Yuan J; Jia R; Bao Y
    J Renin Angiotensin Aldosterone Syst; 2007 Sep; 8(3):118-26. PubMed ID: 17907099
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Puberty permits increased expression of renal transforming growth factor-beta1 in experimental diabetes.
    Lane PH; Snelling DM; Hollman A; Langer WJ
    Pediatr Nephrol; 2001 Dec; 16(12):1033-9. PubMed ID: 11793095
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
    Kamesaki H; Nishizawa K; Michaud GY; Cossman J; Kiyono T
    J Immunol; 1998 Jan; 160(2):770-7. PubMed ID: 9551912
    [TBL] [Abstract][Full Text] [Related]  

  • 58. RAGE- and TGF-beta receptor-mediated signals converge on STAT5 and p21waf to control cell-cycle progression of mesangial cells: a possible role in the development and progression of diabetic nephropathy.
    Brizzi MF; Dentelli P; Rosso A; Calvi C; Gambino R; Cassader M; Salvidio G; Deferrari G; Camussi G; Pegoraro L; Pagano G; Cavallo-Perin P
    FASEB J; 2004 Aug; 18(11):1249-51. PubMed ID: 15180953
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combined effects of moderately elevated blood glucose and locally produced TGF-beta1 on glomerular morphology and renal collagen production.
    Krag S; Nyengaard JR; Wogensen L
    Nephrol Dial Transplant; 2007 Sep; 22(9):2485-96. PubMed ID: 17452404
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Positive feedback loop between plasminogen activator inhibitor-1 and transforming growth factor-beta1 during renal fibrosis in diabetes.
    Seo JY; Park J; Yu MR; Kim YS; Ha H; Lee HB
    Am J Nephrol; 2009; 30(6):481-90. PubMed ID: 19786738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.